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The Sec1p-like/Munc18 (SM) protein Munc18a binds to
the neuronal t-SNARE Syntaxin1A and inhibits SNARE
complex assembly. Tomosyn, a cytosolic Syntaxin1A-
binding protein, is thought to regulate the interaction
between Syntaxin1A and Munc18a, thus acting as a pos-
itive regulator of SNARE assembly. In the present study
we have investigated the interaction between b-Tomo-
syn and the adipocyte SNARE complex involving Syn-
taxin4/SNAP23/VAMP-2 and the SM protein Munc18c, in
vitro, and the potential involvement of Tomosyn in reg-
ulating the translocation of GLUT4 containing vesicles,
in vivo. Tomosyn formed a high affinity ternary complex
with Syntaxin4 and SNAP23 that was competitively in-
hibited by VAMP-2. Using a yeast two-hybrid assay we
demonstrate that the VAMP-2-like domain in Tomosyn
facilitates the interaction with Syntaxin4. Overexpres-
sion of Tomosyn in 3T3-L1 adipocytes inhibited the
translocation of green fluorescent protein-GLUT4 to the
plasma membrane. The SM protein Munc18c was shown
to interact with the Syntaxin4 monomer, Syntaxin4 con-
taining SNARE complexes, and the Syntaxin4/Tomosyn
complex. These data suggest that Tomosyn and Munc18c
operate at a similar stage of the Syntaxin4 SNARE as-
sembly cycle, which likely primes Syntaxin4 for entry
into the ternary SNARE complex.
Soluble N-ethylmaleimide-sensitive factor (NSF)1 attach-
ment protein (SNAP) receptors (SNAREs) play a critical role in
vesicular transport by regulating membrane docking and fu-
sion (1–4). Transport vesicles contain membrane proteins,
known as v-SNAREs, that bind in a highly specific manner to
cognate membrane proteins, t-SNAREs, present in the appro-
priate target membrane. Different sets of v-/t-SNAREs control
discrete membrane transport steps. For example, synaptic ves-
icle exocytosis is facilitated by the t-SNAREs Syntaxin1A and
SNAP25 that localize to the presynaptic plasma membrane and
bind with high affinity to the v-SNARE, VAMP-2, present on
synaptic vesicles (1). A defining feature of v- and t-SNAREs is
the presence of a conserved -helical domain in the juxtamem-
brane region of their cytosolic tail. During SNARE-mediated
membrane fusion, four of these SNARE domains contribute to
a parallel four-helical bundle arrangement (5, 6).
The assembly of functional SNARE complexes in eukaryotic
cells occurs in several discrete stages, each of which represents
a potential site of regulation. For example, there is the priming
step where cis-SNARE complexes, found in both donor and
target membranes, are disassembled by the ATPase NSF and
-SNAP (7, 8). Once primed, tethering machinery may guide
the SNAREs in each membrane into close proximity, and a
proof-reading machinery likely ensures fidelity of the aligned
v-/t-SNARE pairs (9). Following this, formation of the high
affinity trans-SNARE complex results in the committed step of
docking (10). Many different molecules play a role in various
stages of this SNARE assembly cycle. One family of proteins
that regulates SNARE assembly is the Sec1p/Munc18 (SM)
family. However, the role of SM proteins in SNARE assembly is
complex and somewhat controversial (11).
The neuronal SM protein Munc18a binds with high affinity
(Kd  80 nM) to Syntaxin1A, reducing the affinity of
Syntaxin1A for VAMP-2 (12). Consistent with the conclusion
that Munc18a plays a negative role in SNARE complex forma-
tion is the observation that Munc18a does not bind to the
Syntaxin1A/SNAP25/VAMP-2 ternary fusion complex (13–15).
The Syntaxin1A monomer has been shown to adopt a closed
conformation because of interactions between the amino-termi-
nal Habc helical domain and the SNARE-forming H3 helix at
the carboxyl terminus (16). In the ternary complex Syntaxin1A
undertakes a more open conformation, thus facilitating inter-
actions between the H3 domain and the SNARE motifs present
in SNAP25 and VAMP-2 (16, 17). Because Munc18a binds to,
and possibly stabilizes, Syntaxin1A in its closed conformation a
major objective has been to identify factors that could disrupt
the Munc18a/Syntaxin1A heterodimer, thus enhancing
SNARE complex formation. Tomosyn was identified as a mol-
ecule with properties consistent with such a role. Tomosyn was
found to interact specifically with Syntaxin1A and in so doing
displace Munc18a (18).
Tomosyn contains a series of conserved amino-terminal
WD-40 repeats and a carboxyl-terminal VAMP-2-like domain
that is necessary for binding to Syntaxin1A and participation
in a 10 S complex with SNAP25 and the synaptic membrane
protein Synaptotagmin (18–20). Despite the fact that Tomosyn
was shown to interact only with the neuronal t-SNARE
Syntaxin1A its ubiquitous tissue distribution raised the possi-
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bility that it may participate in vesicle transport steps con-
trolled by other syntaxin isoforms (18, 20). Intriguingly, the
v-SNARE VAMP-2, in addition to binding to Syntaxin1A, also
binds to the ubiquitously expressed t-SNARE Syntaxin4 (14,
21). Further, Syntaxin4 has been shown to form an SDS-resist-
ant SNARE complex with SNAP23 and VAMP-2 (22). This
complex plays a role in a number of regulated exocytic pro-
cesses including the insulin-regulated trafficking of the facili-
tative glucose transporter GLUT4 in fat and muscle cells (21–
25). Furthermore, this SNARE complex resembles the synaptic
ternary complex and is subject to regulation by the ubiqui-
tously expressed SM protein Munc18c (21, 26, 27). We have
investigated the role of b-Tomosyn in exocytosis of GLUT4
vesicles and in the assembly of Syntaxin4/SNAP23/VAMP-2
ternary complexes. The present study shows that b-Tomosyn
binds with high affinity to Syntaxin4 via its VAMP-2 like
domain and that overexpression of Tomosyn in 3T3-L1 adipo-
cytes inhibits the insulin-dependent translocation of GLUT4-
eGFP to the cell surface. In contrast to the situation in neurons,
we found that the SM protein Munc18c associated with both
the Syntaxin4/b-Tomosyn binary complex and with the Syn-
taxin4 SNARE complexes. Taken together, our data suggest a
novel role for b-Tomosyn in SNARE complex formation and
vesicle transport and support the hypothesis that Munc18c
plays a fundamental role in the assembly of SNARE core
complexes.
EXPERIMENTAL PROCEDURES
Cloning of 3T3-L1 Adipocyte Tomosyn—Total RNA was prepared
from differentiated 3T3-L1 adipocytes by a single step guanidine iso-
thiocyanate method (28). Reverse transcriptase (RT)-PCR was per-
formed using a standard protocol with oligo(dT) primer (0.5 g) and
total RNA (1 g). Subsequent PCR amplifications were performed using
primers 1, 5cccggatccaccatgaggaaattcaacatc3; and 2, 5cccgaattctcat-
gtgagaaagtcgac3; according to a standardized PCR protocol. The PCR
product of 1050 bp was cloned into a pGEMt easy vector kit (Promega,
Madison, WI) and sequenced using an automated sequencer. The above
PCR was carried out on two successive occasions, and the products were
sequenced independently. Radiolabeled PCR product (rediprimeTM;
Amersham Biosciences) was used to screen a 3T3-L1 adipocyte cDNA
library constructed in  ZAP, kindly provided by Dr. F. Fiedorek (Uni-
versity of North Carolina). Approximately 100,000 plaques were mutu-
ally screened, and one well isolated plaque was excised using Ex-
AssistTM (interference-resistant helper phage with SOLRTM strain) ac-
cording to the manufacture’s protocol (Stratagene, La Jolla, CA). The
cDNA clone was fully sequenced on both strands, and the data were
analyzed using SequencherTM 3.1.1s. 3T3-L1 adipocyte Tomosyn was
98% identical to the neuronal b-Tomosyn splice variant (GenBankTM
accession number AF118889). Our sequencing data derived from the
RT-PCR analysis of 3T3-L1 adipocyte Tomosyn differed from the
cDNA-derived clone of Tomosyn at four amino acids, D238G, H247Y,
A271T, and L301F. These changes do not appear to be random as the
changes are either conserved between our cDNA clone and the pub-
lished rat brain b-Tomosyn sequence (amino acids 238 and 247) or the
RT-PCR product and the respective b-Tomosyn sequence (amino acids
271 and 301).
Plasmid Construction—cDNAs encoding rat Syntaxins-1A, -2, -3,
and -4 and VAMP-2 were generously provided by Dr. R. Scheller (Stan-
ford University). Syntaxin-6- and -7-encoding cDNAs have been de-
scribed (29). Dr. Robert Piper (University of Iowa) provided cDNA
encoding full-length Syntaxin13. The SNAP23 pGEX-4T1 construct has
been described elsewhere (22). Dr. Peter van der Sluijs (Utrecht Uni-
versity School of Medicine, Utrecht, The Netherlands) kindly provided
full-length pRSETA-Rab4-encoding cDNA, which was subcloned into
pGEX-2T as an EcoRI fragment. pcDNA3-Munc18c was constructed by
subcloning a 2.5-kb EcoRI fragment from pMEXneo-Munc18c into the
EcoRI site of pcDNA3 (Invitrogen) (21). The pBluescript KG-Munc18b
and pRSETA-Munc18c constructs have been described (21, 30).
pET20b-Syntaxin4 was kindly donated by Dr. Jenny Martin (Institute
of Molecular Bioscience, Brisbane, Australia). Full-length Tomosyn
cDNA was obtained by PCR using primers 3, 5cccggatccaccatgaggaa-
attcaacatc3; and 4, 5cccgagctcccataagactactgttcc3 from the cDNAs
described in the previous section and was subcloned into triple FLAG
epitope-tagged pMEXneo using BamHI and EcoRI. The FLAG epitope
was constructed using the following primers: 5, 5gaaggatccgtcgacacc-
atggactacaaagaccatgacggtgattataaagatcatgat3; 6, 5atcatgatctttataat-
caccgtcatggtctttgtagtccatggtgtcgacggatccttc3; 7, 5gaagatatcgattacaag-
gatgacgatgacggatccggg3; 8, 5cccggatccgtcatcgtcatccttgtaatcgatatcttc-
3. Primers 5–8 were annealed and digested with EcoRV before being
subcloned as a double stranded fragment into pMEXneo using SalI and
BamHI. Truncated Tomosyn cDNAs encoding bp 1–1050, 1–3225,
1050–3225, and 3199–3459 were obtained by PCR using primers 9,
5cccgaattcaggaaattcaacatc3; 10, 5cccctcgagtcatgtgagaaagtcaac3; 11,
5cccctcgagtcaggaggcctttcccga3; 12, 5cccgaattcacactctgtgaaacg3; 13,
5cccgaattcggagagtcgtcctcg3; and 14, 5cccctcgagtcagaactggtaccactt3.
The Tomosyn cDNAs were cloned into pBTM116 using EcoRI and SalI.
pBTM116-Munc18c and pAct-Syntaxin4 cDNAs were kind gifts from
Dr. Y. Le Marchand-Brustel (Nice, France). eGFP-tagged GLUT4
(GLUT4-GFP-pcDNA3) was received from Dr. J. Pessin (University of
Iowa). All cDNAs obtained by PCR were confirmed by sequencing.
Generation of Antibodies—Rabbit antiserum that specifically recog-
nizes Munc18c was raised against a glutathione S-transferase (GST)
fusion protein comprising a tandem repeat of the carboxyl-terminal 14
amino acids of mouse Munc18c (MLNKSKDKVSFKDE). Following pu-
rification on glutathione-agarose beads (Sigma) the immunogen was
dialyzed against phosphate-buffered saline (PBS) and used to immu-
nize rabbits. Munc18c-specific antibodies were purified using a mono-
meric form of the peptide, immobilized on a Sulfolink gel (Pierce), and
dialyzed against PBS. A polyclonal anti-Syntaxin4 antibody was used
as described (21). Rabbit sera against the cytoplasmic domain of GST-
VAMP-2 was raised according to a standard protocol, and the polyclonal
anti-SNAP23 sera has been described (14, 22). Dr. Y. Takai (Osaka
University Medical School, Osaka, Japan) kindly donated an anti-
Tomosyn antibody (18). A monoclonal Caveolin1 antibody was donated
by Dr. Rob Parton (Institute of Molecular Bioscience, Brisbane, Austra-
lia). The following antibodies were purchased: anti-IRS-1 (Santa Cruz
Biotechnology, Santa Cruz, CA), anti-GFP (Molecular Probes, Eugene,
OR), and anti-LexA (Invitrogen).
Tomosyn Tissue Distribution—Mouse brain and 3T3-L1 adipocyte
samples were prepared in HES buffer (20 mM HEPES, pH 7.4, 250 mM
sucrose, 1 mM EDTA), supplemented with protease and phosphatase
inhibitors (10 g/ml aprotinin, 10 g/ml leupeptin, 25 g/ml phenyl-
methylsulfonyl fluoride, 2 mM sodium vanadate, 1 mM sodium pyro-
phosphate, 1 mM ammonium molbydate, and 10 mM sodium fluoride),
using a glass homogenizer or by passing through a 22- and 27-gauge
needle, respectively. The homogenates were subject to centrifugation at
100,000  gav for 1 h at 4 °C in a Beckman TLA-100.3 rotor. The
supernatant from this spin was used as the cytosol fraction. Protein
concentrations were determined using a Bio-Rad Bradford assay (Her-
cules, CA). Samples were analyzed by SDS-PAGE according to the
method of Laemmli, transferred to polyvinylidene difluoride membrane
(Millipore), and subject to immunoblot analysis (31). Signal was visu-
alized using SuperSignal® West Dura Extended Duration Substrate
(Pierce).
Protein Expression and Purification—Recombinant fusion proteins
encoding GST or GST fused in-frame to the cytosolic domains of the
Syntaxin isoforms-1A, -2, -3, -4, -6, -7, -13, -VAMP-2, -SNAP23, or
full-length -Rab4 were produced in Escherichia coli BL21 (DE3) and
purified using glutathione-Sepharose 4B beads (Amersham Bio-
sciences) according to standard procedures. Histidine (His6)-tagged
Munc18c and Syntaxin4 were made in Sf9 and BL21 (DE3) cells,
respectively, and purified using TALONTM Cobalt metal affinity resin
according to the supplier’s protocol (Clontech, Palo Alto, CA). The
recombinant proteins were dialyzed against PBS, except His6-Munc18c,
which was dialyzed against PBS containing 2 mM 2-mercaptoethanol,
and concentrated using Aquacide (Calbiochem). The protein concentra-
tion and purity of all recombinant fusion proteins were determined by
Bio-Rad Bradford protein assays and SDS-PAGE followed by staining
with Coomassie Blue. GST-VAMP-2 was cleaved with thrombin (25
units/ml) (Amersham Biosciences) in 50 mM Tris, pH 8.0, 150 mM NaCl,
2.5 mM CaCl2, 0.1%, 2-mercaptoethanol. Phenylmethylsulfonyl fluoride
(25 g/ml) was added to the reaction, and the thrombin-cleaved protein
was dialyzed against PBS.
Recombinant Fusion Proteins—Recombinant GST fusion proteins
(5–15 g) were attached to glutathione-Sepharose beads (15–25 l) in a
total volume of 300–350 l of PBS for 1 h at 20 °C and recovered by brief
centrifugation. His6-tagged fusion proteins were incubated with TAL-
ONTM resin (25–50 l) in the same way. Binary (Syntaxin4/SNAP23;
Syntaxin4/VAMP-2; SNAP23/VAMP-2; Syntaxin4/Munc18c) or ternary
(Syntaxin4/SNAP23/VAMP-2) complexes were formed by mixing ap-
proximately equimolar amounts of recombinant proteins and incubated
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either for 2 h or overnight at 4 °C in PBS or PBS containing 0.1–0.2%
Triton X-100 and 0.1% bovine serum albumin (BSA). The complexes
were further incubated with resin as described above.
In Vitro Binding Assay—Recombinant GST or His6-tagged proteins,
attached to glutathione-Sepharose or metal affinity resin, were incu-
bated with 0.8–1.0 ml of purified 3T3-L1 adipocyte cytosol (1–3 mg/ml)
or mouse brain cytosol, containing 120 mM NaCl, 0.1% BSA, and 1%
Triton X-100, for 2 h at 4 °C. Alternatively, recombinant SNARE pro-
teins were incubated with 20 l of [35S]methionine-labeled Munc18-b or
-c (TNT® Coupled Reticulocyte Lysate System; Promega) in 0.5 ml of
binding buffer (20 mM HEPES, pH 7.5, 120 mM NaCl, 0.2% Triton
X-100, and 0.1% BSA) as described above. After washing the samples
three to four times with PBS or binding buffer (lacking BSA), the
proteins attached to the affinity beads were solubilized in 20 l of 2 
SDS-sample buffer containing 100 mM dithiothreitol and heated for 5
min at 100 °C. Data were analyzed by SDS-PAGE followed by Autora-
diography (Eastman Kodak Co. BioMax MR film; Rochester, NY) or im-
munoblotted using specific antibodies and stained with 0.5% Ponceau S
in 0.5% trichloroacetic acid or Coomassie Blue stain.
Yeast Two-hybrid Methods—A standard lithium acetate/single-
stranded carrier DNA/polyethylene glycol method for transformation
into yeast strain L40 was used, and expression of proteins fused to LexA
was checked by SDS-PAGE and immunoblotted. Transcriptional acti-
vation of LacZ was determined using the X-Gal filter lift assay and a
quantitative liquid assay, using the substrate nitrophenyl--D-galacto-
pyranoside as described (32, 33). For the filter lift assay color develop-
ment within 0–3 h was scored () and development within 3–6 h
was scored (); no color after 16 h was scored negative.
Cell Culture—3T3-L1 adipocytes were cultured as described (34).
Experiments were performed using adipocytes between 7 and 17 days
post-differentiation. Before experimental use the cells were starved in
Dulbecco’s modified Eagle’s medium lacking fetal calf serum over night
at 37 °C with 5% CO2 (v/v) and either used in a basal condition or
stimulated with insulin (4 g/ml) for 15 min. N-Ethylmaleimide (NEM)
treatment was carried out using 1 mM NEM in Me2SO for 15 min at
37 °C before subcellular fractionation. Electroporation was performed
essentially as described by Pessin and co-workers (26), using 100 g
of cesium chloride-purified GLUT4-eGFP-pcDNA3 and 400 g of
pMEXneo, pMEXneo-Munc18c, or pMEXneo-FLAG-Tomosyn. The electro-
porated cells were seeded on 1% gelatin-coated coverslips or 10-cm
tissue culture dishes and either fixed in 2% paraformaldehyde or sub-
jected to subcellular fractionation (35). Fixed cells were quenched using
50 mM ammonium chloride and blocked/permeabilized in BB (2% BSA
and 0.1% saponin in PBS) before GLUT4-eGFP was visualized using a
primary GFP antibody (1:300) and Alexa 488-conjugated secondary
antibody (1:150) in BB. Immunofluorescence images were obtained
using a Zeiss Axioskop 40 fluorescence microscope (63 objective) and
analyzed using Zeiss AxioVision software.
Subcellular Fractionation of 3T3-L1 Adipocytes—Subcellular frac-
tionation was carried out according to an established protocol to gen-
erate membrane fractions that are enriched in markers of the plasma
membrane (PM), endoplasmic reticulum and endosomes (high density
microsomes, HDM), Golgi membranes, recycling endosomes, and the
majority of the intracellular GLUT4 responsive compartment (low den-
sity microsomes, LDM), mitochondria/nuclei, and cytosol (35, 36).
Statistical Analysis—Statistical analyses were performed using Ex-
cel software. Statistical significance was established using a Student’s
t test.
RESULTS
Tomosyn has been shown to disrupt the neuronal Munc18a/
Syntaxin1A complex by binding to Syntaxin1A and has thus
been proposed to be a positive modulator of SNARE complex
formation, overcoming the negative regulatory role of Munc18a
(18). We have demonstrated previously (22) that VAMP-2
forms a high affinity SNARE complex with Syntaxin4 and
SNAP23. This complex regulates a variety of exocytic transport
events including the translocation of GLUT4 to the plasma
membrane of adipocytes and the translocation of water chan-
nels to the cell surface of kidney cells (23, 37–39). Tomosyn
binds to Syntaxin1A via a helical domain that is homologous to
the VAMP-2 SNARE motif, and a recently described molecule,
Amisyn, contains a Tomosyn-like SNARE motif and has fur-
ther been shown to interact with both Syntaxin1A and Syn-
taxin4 from rat brain (18, 20, 40). Therefore, we set out to
investigate whether Tomosyn binds to Syntaxin4 and whether
it plays a similar role in destabilizing the Syntaxin4/Munc18c
complex to that observed in neurons.
Tomosyn Is a Ubiquitously Expressed Protein—Tomosyn was
originally identified as a 120–130-kDa Syntaxin1A-binding
protein that is highly expressed in neuronal tissue. An immu-
noreactive species was also demonstrated to be present in other
tissues (18). Using a Tomosyn-specific antibody we verified the
ubiquitous expression of this protein in tissue including heart,
spleen, lung, skeletal muscle, liver, and kidney (data not
shown). We also showed that Tomosyn is expressed in 3T3-L1
adipocytes, a cell line that is commonly used to study the
insulin-dependent trafficking of GLUT4 (18, 41). Takai and
co-workers (20) identified three Tomosyn splice variants re-
ferred to as s-, m-, and b-Tomosyn (20). To determine which
isoform is expressed in adipocytes we cloned Tomosyn from a
3T3-L1 adipocyte cDNA library (see “Experimental Proce-
dures”) and verified that it corresponds to the b-Tomosyn iso-
form found in rat brain. This is consistent with RT-PCR data
from Takai and co-workers (20) showing that b-Tomosyn is
ubiquitously expressed.
Tomosyn Binds Specifically to the VAMP-2 t-SNAREs
Syntaxin1A and Syntaxin4—In light of the observation that
Tomosyn binds to Syntaxin1A via its VAMP-2-like domain and
that VAMP-2 binds to Syntaxins-1A and -4, we set out to
investigate the Syntaxin binding spectra of b-Tomosyn (12, 14,
18, 20, 21). We assessed the ability of GST fusion proteins
containing the entire cytosolic domain of Syntaxin-1A, -2, -3, -4,
-6, -7, or -13 to bind b-Tomosyn from 3T3-L1 adipocyte cytosol
in vitro (Fig. 1). It was necessary to use cytosol as a source of
b-Tomosyn, because, as reported previously (18), we found that
recombinant Tomosyn was insoluble when produced as a bac-
terial fusion protein. Immunoblot analysis of subcellular
3T3-L1 adipocyte fractions, obtained through differential cen-
trifugation, demonstrated that b-Tomosyn is predominantly
cytosolic, and therefore adipocyte cytosol was used as a source
of Tomosyn in all our in vitro binding experiments (see Fig. 6)
(35). In agreement with Fujita et al. (18), b-Tomosyn bound
avidly to Syntaxin1A (Fig. 1, lane 2). In addition, Tomosyn also
bound to Syntaxin4 (lane 5). Similar results were obtained
using rat brain cytosol as a source of Tomosyn (data not
shown). There was no detectable binding of Tomosyn to GST
alone or GST-Syntaxins-2, -3, -6, -7, and -13. These studies
were performed using similar concentrations of each fusion
protein as indicated by the Ponceau S stain. There was seven
FIG. 1. b-Tomosyn binds to Syntaxin1A and Syntaxin4. Recom-
binant GST or GST-Syntaxin isoforms-1A, -2, -3, -4, -6, -7, and -13 (15
g) were used in an in vitro pull-down assay. The fusion proteins were
pre-adsorbed to glutathione-Sepharose and incubated with purified
3T3-L1 adipocyte cytosol, as a source of b-Tomosyn, for 2 h at 4 °C
before extensive washing. Interacting proteins were separated by SDS-
PAGE (10%) and immunoblotted with an anti-Tomosyn antibody. The
right lane shows a small amount (0.5%) of the total cytosol lysate used
for the binding assay. Recombinant proteins were visualized with 0.5%
Ponceau S in 0.5% trichloroacetic acid.
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times more b-Tomosyn bound to Syntaxin1A than to Syn-
taxin4, indicating that it has a stronger avidity for the neuro-
nal isoform. This parallels the binding affinity of the v-SNARE
VAMP-2, which has also been reported to bind with greater
affinity to Syntaxin1A than to Syntaxin4 (12, 21).
Tomosyn Binding to the Binary Syntaxin4/SNAP23 Com-
plex—We went on to determine whether b-Tomosyn could form
a complex with the t-SNAREs Syntaxin4 and SNAP23 similar
to VAMP-2. Fig. 2 demonstrates that there was a weak but
specific interaction between b-Tomosyn and SNAP23 alone
(lane 2). These data are consistent with the reports by Scheller
and co-workers (40, 42), who demonstrated an interaction be-
tween the carboxyl terminus of Tomosyn and SNAP23 in a
yeast two-hybrid study and a weak interaction between Ami-
syn and SNAP25. There was no detectable binding of b-Tomo-
syn to either recombinant VAMP-2 or Rab4. Strikingly, the
amount of Tomosyn that was bound to the Syntaxin4/SNAP23
SNARE complex (lane 5) was substantially greater than with
either monomeric Syntaxin4 (lane 1) or SNAP23 (lane 2) alone.
Quantitation of data from three to four separate experiments
revealed that the amount of Tomosyn bound to either Syn-
taxin4 or to the Syntaxin4/SNAP23 dimer was 12.5-fold and
52-fold greater, respectively, than that bound to SNAP23 alone
(Fig. 2B). This indicates that these proteins form a high affinity
ternary complex similar to that reported previously for Syn-
taxin4/SNAP23/VAMP-2 (22, 23).
The VAMP-2-like Domain of Tomosyn Is Sufficient for the
Syntaxin4 Interaction—To confirm that b-Tomosyn binds to
Syntaxin4 via its VAMP-2-like domain we performed competi-
tion binding studies using recombinant VAMP-2. Fig. 3A shows
the binding of b-Tomosyn to the Syntaxin4/SNAP23 dimer in
the presence of increasing concentrations of VAMP-2. We ob-
served quantitative inhibition of b-Tomosyn binding to the
Syntaxin4/SNAP23 heterodimer when VAMP-2 was present in
approximately equimolar concentrations (0.25 nmol/l) (lane
3). The Ponceau S stain indicates that each lane contains a
constant amount of GST-Syntaxin4 and GST-SNAP23. A re-
cent study has shown that mammalian lethal giant larvae, a
homolog of Drosophila tumor suppressor protein lethal (2) gi-
ant larvae and of Tomosyn, interacts with Syntaxin4 in the
basolateral membrane of Madin-Darby canine kidney cells (43).
This was surprising, as both the family of lethal (2) giant larvae
proteins and the yeast homolog of Tomosyn, Sro7/77, do not
contain a SNARE motif. However, there is significant sequence
conservation in the amino-terminal part among lethal giant
larvae proteins, Sro7/77 and Tomosyn, including a series of
WD-40 repeats (19, 44). We therefore investigated whether this
conserved amino-terminal part of Tomosyn could interact with
Syntaxin4 independently of the VAMP-2 like domain. Four
different Tomosyn truncations were constructed, comprising
amino acids 1–350, 350–1075, 1–1075, and 1066–1153, and
used as baits in a yeast two-hybrid study where Syntaxin4 was
prey (Fig. 3B). None of the Tomosyn baits showed intrinsic
transcriptional activation in the absence of prey and vice versa
for the prey alone (data not shown). Consistent with our in vitro
binding studies, we observed a strong interaction between the
VAMP-2-like domain of Tomosyn, amino acids 1066–1153, and
FIG. 2. b-Tomosyn forms a ternary complex with the t-SNAREs
Syntaxin4 and SNAP23. A, GST-tagged Syntaxin4, -SNAP23,
-VAMP-2, -Rab4, and -Syntaxin4/-SNAP23 (binary complexes) (15 g)
were mixed with glutathione-Sepharose and incubated with purified
adipocyte cytosol as described in the legend to Fig. 1. Samples were
analyzed by SDS-PAGE and immunoblotted using the Tomosyn anti-
body. Recombinant fusion proteins were detected with 0.5% Ponceau S
stain. B, autoradiograms from three to four independent experiments
were scanned using a densitometer (Molecular Dynamics) and analyzed
using IP Lab GelH software (Signal Analytics). Data represent mean 
S.D.
FIG. 3. b-Tomosyn binds to Syntaxin4 via its VAMP2-like do-
main. A, preformed GST-Syntaxin4/-SNAP23 complexes were incu-
bated with increasing amounts of GST-VAMP-2 (0, 0.083, 0.25, or 0.75
nmol/l). The recombinant protein complexes were isolated using glu-
tathione-Sepharose and assayed for their ability to bind b-Tomosyn
from adipocyte cytosol. B, baits, pLex empty vector (1), Tomosyn amino
acids 1075–1153 (2), Tomosyn 1–1075 (3), Tomosyn 1–350 (4), Tomosyn
350–1075 (5), and full-length Munc18c (6), were co-expressed with
Syntaxin4 (prey) in yeast strain L40. Transcriptional activation of LacZ
was assessed using an X-Gal filter lift assay. The X-Gal filter lift assay
shown is representative of both 3- and 16-h incubations in the presence
of substrate. A quantitative liquid assay was carried out using nitro-
phenyl--D-galactopyranoside as substrate, and the results are shown
in parentheses in milli -Gal units below each relevant track. Interac-
tions that were significantly different from the negative control are
represented as *, p  0.01.
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Syntaxin4 (Fig. 3B), whereas no significant interaction was
observed for the amino terminus, the middle domain, or full-
length Tomosyn lacking the SNARE motif (panels 3 to 5).
Full-length Munc18c and pLex (a potent autoactivator) were
used as positive controls for LacZ transcriptional activation
(panels 6 and 1, respectively). The data obtained from the
liquid-assay are shown in parentheses below each panel (Fig.
3B). Collectively, these data preclude a role for the conserved
amino-terminal domain of Tomosyn in binding to Syntaxin4, a
role assigned to the VAMP-2-like SNARE motif of Tomosyn.
Expression of Tomosyn in 3T3-L1 Adipocytes Inhibits
GLUT4-eGFP Translocation—Dissociation of the Munc18c/
Syntaxin4 heterodimer may represent a key regulatory event
in insulin-dependent translocation of GLUT4. Because Tomo-
syn has been implicated in controlling this event in neurons,
and our studies indicate that Tomosyn is involved in t-/v-
SNARE complex formation, in vitro, we examined the role of
Tomosyn in insulin-stimulated GLUT4 trafficking using a
3T3-L1 adipocyte model. FLAG-epitope tagged Tomosyn or
empty vector were co-expressed with GLUT4-eGFP in adipo-
cytes by electroporation. The electroporated cells were either
used in the basal state or stimulated with insulin for 15 min,
fixed in 2% paraformaldehyde, and scored for plasma mem-
brane staining using a fluorescence microscopy assay as de-
scribed previously (Fig. 4A) (26). To validate the GLUT4-eGFP
assay, Munc18c, which is known to inhibit GLUT4 transloca-
tion, was co-expressed with GLUT4-eGFP and scored in an
identical manner to the Tomosyn-expressing cells (panels b and
e) (26, 45). Insulin caused a 7-fold increase in the total number
of cells displaying positive GLUT4-eGFP surface labeling (Fig.
4). Co-expression of either Munc18c or Tomosyn caused an
approximate 50% decrease in the number of cells displaying
GLUT4 surface labeling following insulin treatment. The ex-
pression of GLUT4-eGFP was similar in each of the treatment
groups, suggesting that Tomosyn or Munc18c overexpression
had no significant effect on the expression of the reporter. To
further substantiate the effects of Tomosyn overexpression on
GLUT4 translocation, we next performed subcellular fraction-
ation on electroporated adipocytes (Fig. 5) (35). The subcellular
distribution of GLUT4-eGFP was similar to that described
previously for endogenous GLUT4. In the absence of insulin,
GLUT4-eGFP was sequestered in an intracellular compart-
ment, highly enriched in the LDM fraction, and translocated to
the cell surface from the LDM with insulin (Fig. 5, lanes 1 and
2) (46–49). Consistent with our immunofluorescence data,
overexpression of Tomosyn caused a 40% block in the move-
ment of GLUT4-eGFP containing vesicles to the plasma mem-
brane (0.64  0.06, p  0.05). Intriguingly, overexpression of
Munc18c caused an increase in the amount of GLUT4-eGFP
found at the PM under basal conditions. However, the incre-
mental increase at the plasma membrane in response to insulin
was less in cells overexpressing Munc18c compared with con-
trol cells. This was readily apparent from the reduced insulin-
stimulated decrement in GLUT4-eGFP in the LDM fraction
from both the Munc18c and Tomosyn overexpressing cells.
Taken together, these data implicate Tomosyn in the regula-
tion of GLUT4 trafficking, similar to Munc18c.
Tomosyn and Munc18c Dissociate from Membranes in the
Presence of NEM—The t-SNARE Syntaxin4 is an integral
membrane protein, highly enriched in the PM, whereas both
Tomosyn and Munc18c encode soluble proteins, lacking trans-
membrane domains (21, 50). To ascertain the subcellular dis-
tribution of Tomosyn, we employed subcellular fractionation as
described in Fig. 5. Consistent with previous studies Syntaxin4
was highly enriched in the PM fraction (Fig. 6A) (21, 26). The
majority of Tomosyn was soluble and found in the cytosol
FIG. 4. Overexpression of Tomosyn and Munc18c inhibits in-
sulin-stimulated GFP-GLUT4 movement to the PM. A, differenti-
ated 3T3-L1 adipocytes were co-electroporated with 100 g of
GFP-GLUT4-pcDNA3 and 400 g of either pMEXneo, pMEXneo-
Munc18c, or pMEXneo-FLAG-Tomosyn and replated onto gelatin-coated
coverslips. At 36 h after replating the cells were incubated in the
absence (A, B, and C) or presence of insulin (107 M) for 15 min (D, E,
and F) before fixation in 2% paraformaldehyde. Shown are represent-
ative immunofluorescence images. B, quantitation of surface staining
expressed as percent cells demonstrating plasma membrane staining.
An average of 200 cells/coverslip, from randomly picked fields, were
scored per condition. Shown are mean data  S.D. of four separate
coverslips per condition from two separate experiments. *, p  0.01
compared with control cells incubated with insulin.
FIG. 5. Expression of exogenous Tomosyn and Munc18c inhibit
the translocation of GFP-GLUT4 vesicles to the PM. Electropora-
tion of adipocytes was carried out as described in the legend for Fig. 4.
The cells were allowed to recover on gelatin-coated tissue culture
dishes, incubated in the absence or presence of insulin, and subjected to
subcellular fractionation to obtain membranes enriched for PM and
LDM markers. Equivalent amounts of protein were loaded and ana-
lyzed by SDS-PAGE (10%) and immunoblotted using antibodies against
GFP, Caveolin1, IRS-1, and SNAP23. Lane 7 shows cells not expressing
GFP-GLUT4. The relative migration of molecular weight standards is
shown at the left.
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fraction (98%), but interestingly, a significant amount was
also present in the PM and LDM fractions (Fig. 6A). Similar to
Syntaxin4, the subcellular distribution of Tomosyn did not
change with insulin (Fig. 6). We have attempted to determine
whether the interaction of Tomosyn with the membrane is
facilitated via Syntaxin4 binding using immunoprecipitation.
However, these studies have failed to identify such an interac-
tion possibly because of the affinity of the interaction or maybe
because of the presence of endogenous factors that dissociate
the complex. To overcome such problems we have attempted to
inhibit the enzyme NSF by incubating cells with NEM (51–53)
reasoning that this enzyme may catalyze the disassembly of
Tomosyn complexes. Although we observed an increase in Syn-
taxin4 ternary complex formation with NEM (data not shown)
surprisingly under these conditions we found that Tomosyn
dissociated from membranes into the cytosol (Fig. 6B). Strik-
ingly, Munc18c was also released from the membrane in re-
sponse to NEM in a similar manner to Tomosyn.
Binding of Tomosyn to the Munc18c/Syntaxin4 Complex—
Neuronal Tomosyn has been proposed to regulate exocytosis of
small synaptic vesicles by competing with Munc18a for
Syntaxin1A binding (18). In support of this hypothesis, Tomo-
syn and Munc18a binding to Syntaxin1A were shown to be
mutually exclusive and precede ternary complex formation
(18). To ascertain whether Tomosyn similarly regulates Syn-
taxin4/SNAP23/VAMP-2 ternary complex formation, we set out
to investigate the interactions between b-Tomosyn, Syntaxin4,
and Munc18c (Fig. 7). In vitro binding assays were performed
using purified adipocyte cytosol, as a source of b-Tomosyn, and
recombinant fusion proteins. Consistent with our previous data
(see Figs. 1 and 2) b-Tomosyn bound avidly to recombinant
His6-Syntaxin4 (Fig. 7A), and no direct interaction between
b-Tomosyn and His6-Munc18c was detected. Subsequently, we
used preformed GST-Syntaxin4/His6-Munc18c complexes for
binding of Tomosyn from adipocyte cytosol (Fig. 7B). Impor-
tantly, under these conditions Tomosyn could only be bound to
the Munc18c/Syntaxin4 dimer, because Tomosyn does not bind
to Munc18c alone. Interestingly, we observed a significant in-
teraction between b-Tomosyn and the Munc18c/Syntaxin4
dimer (Fig. 7B). This was not because of an interaction between
b-Tomosyn and Syntaxin4 alone, as there was no detectable
binding of b-Tomosyn when the same binding reaction was
performed in the absence of recombinant Munc18c (lane 4).
These data suggest that b-Tomosyn can bind both to the Syn-
taxin4 monomer and to the Syntaxin4/Munc18c complex. On
occasions we observed a different mobility of b-Tomosyn pres-
ent in the cytosol lysate compared with immunoreactive Tomo-
syn in the SNARE complex samples, seen in Fig. 7. This aber-
rant mobility of b-Tomosyn in the lysate was likely because of
the high protein and detergent concentrations in this fraction.
Munc18c Binds to the Syntaxin4 SNARE Complex—The ob-
FIG. 6. Intracellular localization of Tomosyn and Syntaxin4 in
3T3-L1 adipocytes. A, 3T3-L1 adipocytes were subjected to subcellu-
lar fractionation to obtain PM, LDM, high density microsomes (HDM),
mitochondria/nuclei (M/N), and cytosol (Cyt) fractions as previously
described (35, 36). Equivalent amounts of protein for each fraction was
analyzed by SDS-PAGE (10%) and immunoblotted with antibodies spe-
cific for Tomosyn and Syntaxin4. B, 3T3-L1 adipocytes were incubated
in the absence or presence of 1 mM NEM. The cells were subjected to
subcellular fractionation, and equivalent amounts of protein were im-
munoblotted with antibodies specific for Tomosyn, Munc18c, and
Caveolin1. The relative migration of molecular weight standards is
shown at the left.
FIG. 7. Munc18c and b-Tomosyn binding to Syntaxin4 is not
mutually exclusive. A, purified His6-tagged Munc18c (14 g) or His6-
Syntaxin4 (12 g) were incubated with purified 3T3-L1 adipocyte cy-
tosol for 2 h at 4 °C, recovered using TALONTM metal affinity resin and
washed extensively before analysis. B, His6-Munc18c (14 g) and GST-
tagged Syntaxin4 (12 g) were either mixed or assayed individually for
their ability to bind b-Tomosyn as described above. Samples were an-
alyzed by SDS-PAGE (10%) and immunoblotted with antibodies against
Tomosyn, Munc18c, and Syntaxin4. Right-hand lanes show an aliquot
of cytosol (7.5 g). Recombinant fusion proteins were visualized using
either Ponceau S or Coomassie Blue.
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servation that Tomosyn and Munc18c can bind to Syntaxin4
simultaneously was surprising in view of previous findings
using Munc18a and the neuronal SNAREs (18). Moreover, be-
cause b-Tomosyn binds to Syntaxin4 in a manner that parallels
VAMP-2 binding, we reasoned that Munc18c might interact
with other Syntaxin4 containing complexes, including the ter-
nary fusion competent SNARE complex. To determine whether
Munc18c binds to SNARE complexes, it was necessary to purify
these complexes without the presence of monomeric Syntaxin4.
This was achieved using recombinant fusion proteins compris-
ing His6-Syntaxin4, GST-SNAP23, GST-VAMP-2, or thrombin-
cleaved VAMP-2, in various combinations to produce binary
and ternary complexes, which were subsequently isolated us-
ing glutathione-Sepharose (Fig. 8). Recombinant Munc18-b
and -c were produced as untagged, in vitro translated, [35S]me-
thionine-labeled entities for detection by autoradiography. In-
terestingly, we observed significant binding of Munc18c to the
SNARE complex comprised of His6-Syntaxin4/GST-SNAP23/
GST-VAMP-2 and VAMP-2 (Fig. 8A, lanes 1 and 2). In addition,
the His6-Syntaxin4/GST-VAMP-2 dimer and to a lesser extent
the His6-Syntaxin4/GST-SNAP23 binary complex also inter-
acted specifically with Munc18c in our assay (lanes 3 and 5).
We failed to detect any significant interaction between
Munc18c and the GST-SNAP23/VAMP-2 heterodimer (lane 4)
or to GST-SNAP23 alone (lane 6). The amount of nonspecific
binding of radiolabeled Munc18c or His6-Syntaxin4 to the glu-
tathione-Sepharose was negligible, as seen by the appropriate
controls (lanes 10 and 11). In addition, no binding of the ubiq-
uitously expressed SM protein Munc18b to the recombinant
SNARE complexes was detected, showing that nonspecific
binding to coiled-coil proteins in our binding assay was mini-
mal (Fig. 8B). These data suggest that Munc18c is capable of
interacting with Syntaxin4 while present in complexes with its
SNARE partners SNAP23 and VAMP-2, including the ternary
fusion competent complex.
DISCUSSION
We have further characterized the properties of Tomosyn,
originally identified as a Syntaxin1A-binding protein in neural
tissue, and report several novel observations extending earlier
studies (18). First, we show that in addition to binding to
Syntaxin1A, b-Tomosyn also interacts with the ubiquitously
expressed t-SNAREs Syntaxin4 and SNAP23. This binding
was specific, as we failed to observe an interaction between
b-Tomosyn and other Syntaxin isoforms. Further, this interac-
tion was mediated via the carboxyl-terminal VAMP2-like do-
main in Tomosyn, indicating that the amino-terminal part
encodes an alternate function. Second, we have obtained func-
tional data showing that overexpression of full-length Tomosyn
in adipocytes inhibits insulin-dependent translocation of
GLUT4. Finally, we show that Munc18c interacts both with the
Tomosyn/Syntaxin4 complex, as well as the Syntaxin4 contain-
ing SNARE complex. Collectively these data implicate a novel
role for Tomosyn in the insulin-regulated trafficking of GLUT4
and suggest that it may act in concert with the SM protein
Munc18c to prime the t-SNARE for subsequent docking.
Tomosyn was originally described as a Syntaxin-binding pro-
tein with a function confined to regulated exocytosis of synaptic
vesicles, utilizing Syntaxin1A as a t-SNARE (18). However, our
studies demonstrate that ubiquitously expressed b-Tomosyn
binds with high affinity to the ubiquitously expressed
t-SNAREs Syntaxin4 and SNAP23 (see Figs. 1–3), suggesting
that b-Tomosyn plays a more widespread role in regulating
exocytosis in all cells. The t-SNAREs Syntaxin4 and SNAP23
have been implicated in a variety of cell surface transport
events, including the insulin-regulated translocation of GLUT4
containing vesicles, vasopressin-regulated trafficking of aqua-
porins, platelet -granule secretion, and IgE receptor-induced
degranulation (22–25, 38, 39, 54, 55). Hence, it is conceivable
that b-Tomosyn plays a role in each of these regulatory
processes.
Structural studies have revealed that Syntaxin1A may exist
in either a closed or an open conformation and that Munc18a
selectively binds to the closed conformation, thus acting as a
clamp on vesicle transport (16, 17). Tomosyn was described as
a molecule with potential to displace Munc18a from
Syntaxin1A, thus stimulating vesicle transport (18). Based on
our study it is clear that the Syntaxin4 SNARE complex is
FIG. 8. Munc18c binds to the ternary SNARE complex. A and B,
His6-Syntaxin4, GST-SNAP23, GST-VAMP-2, or thrombin-cleaved
VAMP-2 containing complexes (10 g each) were preincubated with
PBS containing 0.2% Triton X-100 and 0.1% BSA at 4 °C overnight and
then incubated with in vitro translated [35S]methionine-labeled
Munc18c (A) or Munc18b (B), respectively. Recombinant protein com-
plexes were recovered by addition of glutathione-Sepharose and washed
extensively before Munc18 binding was determined by SDS-PAGE
(10%) and autoradiography using MR BioMax film. SDS-PAGE (10 and
15%) followed by Coomassie Blue staining or Western blotting of the
samples from A were carried out to confirm loading. The relative mi-
gration of molecular weight standards is shown at the left.
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regulated in a different manner to its neuronal counterpart.
Munc18c binds to both the Syntaxin4 monomer and the Syn-
taxin4 SNARE complex containing VAMP-2 and/or SNAP23
(Fig. 8). Notably, two alternate SM proteins in yeast, Sly1p and
Vps45p, have also been shown to interact both with their cog-
nate Syntaxins and SNARE complexes (56–59). Hence, these
data suggest that SM proteins, including Munc18c, can bind
both the open and closed form of Syntaxin, or alternatively that
the non-neuronal Syntaxins do not adopt a closed conforma-
tion. These data do not support a model where SM proteins act
as negative regulators of SNARE assembly. Consequently, it
was perhaps not surprising that the interaction we observed
between Tomosyn and Syntaxin4 did not conform to that de-
scribed previously in neurons. Our data indicate that the in-
teraction between Tomosyn and Syntaxin4 is not prevented by
the presence of Munc18c, as both molecules could bind simul-
taneously (Fig. 7). These data are consistent with the observa-
tion that Tomosyn binds to Syntaxin4 via its VAMP-2-like
domain and that both VAMP-2 and Tomosyn bind to Syntaxin4
in a manner that does not preclude an interaction with
Munc18c. A previous study showed that the first 139 amino
acids of Munc18c (domain 1) are sufficient for syntaxin4 bind-
ing (60). Based on the crystal structure of the Munc18a/
Syntaxin1A dimer, domain 1 in Munc18a contacted regions in
both the Habc and H3 domains of Syntaxin1A (17). Thus, it will
be informative to determine the contact sites between Syn-
taxin4 and Munc18c, particularly because recent studies using
yeast SM proteins have revealed distinct modes of interaction
(61, 62).
Our new data place the point of action of Tomosyn close to
that of Munc18c in the SNARE assembly cycle. First, both
proteins bind to Syntaxin4 and can interact with Syntaxin4
binary complexes. Second, when overexpressed in adipocytes
both Tomosyn and Munc18c inhibited insulin-stimulated
GLUT4 translocation to a similar extent (see Figs. 4 and 5).
Moreover, overexpression of Munc18c also appeared to enhance
the level of GLUT4-eGFP in the plasma membrane under basal
conditions (Fig. 5). This may reflect a role for Munc18c in
promoting SNARE assembly, a concept that has been reported
previously (63) for other SNARE complexes. As to why
Munc18c overexpression should enhance cell surface levels of
GLUT4-eGFP under basal conditions but block insulin action
remains to be determined. Perhaps the inhibitory effect on
insulin action is mediated via an interaction between Munc18c
and some part of the insulin-regulated vesicle transport ma-
chinery. It is noteworthy that we2 and others (64) have ob-
served insulin regulation of the exocyst complex in adipocytes,
and so it will be of interest to determine whether this effect is
inhibited by over expression of Munc18c. Moreover, it will also
be important to establish the mechanism for the inhibitory
effect of Tomosyn overexpression on GLUT4 trafficking, be-
cause this may involve its interaction with the t-SNAREs Syn-
taxin4 and SNAP23 or some other regulatory machinery.
Third, incubation of cells with NEM stimulated the release of
both Tomosyn and Munc18c from the plasma membrane into
the cytosol. Because NEM is known to have a profound effect on
SNARE assembly through NSF, these data suggest that both
Tomosyn and Munc18c may cycle on and off membranes at a
similar stage of the vesicle transport cycle. We have shown
recently (65) that the SM protein Vps45p cycles on and off
membranes during the SNARE cycle in a manner that is reg-
ulated by phosphorylation. Hence, it will be interesting to
examine the potential role of insulin-induced phosphorylation
concerning the interaction of Munc18c with the plasma
membrane.
Intriguingly, the domain structure of Tomosyn resembles
that of the Golgi tethering protein p115. Tomosyn and p115 are
of similar size and importantly contain a coiled-coil domain at
their carboxyl termini that resembles the SNARE motif (66,
67). p115 is thought to act as a tethering molecule by first
linking Giantin on COP1-coated transport vesicles with the
Golgi protein GM130 and subsequently promoting SNARE
complex assembly on the target membrane (67, 68). This role is
consistent with the observation that expression of full-length
Tomosyn was required to inhibit exocytosis, in vivo, and might
indicate a separate but necessary role for the conserved amino-
terminal domain of Tomosyn (18). It will be of interest to
determine whether Tomosyn binds to GLUT4 containing vesi-
cles and if so, to determine the molecular basis for this inter-
action. However, it is also conceivable that Tomosyn acts as a
substitute coiled-coil, forming a soluble four-helix bundle with
the PM t-SNAREs. Such t-SNARE/Tomosyn or Amisyn bundles
could represent activated and fusogenic SNARE complexes
(40). The t-SNARE Tlg2p has been shown previously (40, 69) to
require activation by its cognate v-SNARE, Snc2p, or a peptide
encompassing the coiled-coil region of Snc2p, suggesting a po-
tential role for Tomosyn/Amisyn-like proteins in t-SNARE ac-
tivation. In addition, t-SNARE/Tomosyn and Amisyn com-
plexes have been co-immunoprecipitated from solubilized
membranes, although these complexes are not abundant or of a
transient nature in intact cells, as only a fraction of the t-
SNAREs co-sedimented (18, 40). These studies raise a number
of important questions for future investigation. What is the role
of the Tomosyn amino terminus in vesicle transport? Is there
also a role for the related proteins Amisyn and mammalian
lethal giant larvae in insulin-regulated GLUT4 trafficking in
adipocytes? These proteins have been described as additional
Syntaxin4-binding proteins, yet they do not possess an appar-
ent VAMP2-like domain like that found in Tomosyn (18, 20, 40,
43). So the mechanism for their interaction with the t-SNARE
remains to be determined.
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